Thrombus formation on angioplasty equipment during primary Percutaneous coronary intervention for acute st elevation myocardial infarction despite intravenous Enoxaparin use: Case report
Küçük Resim Yok
Tarih
2013
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
ABS TRACT Unfractionated heparin (UFH) has been traditionally used as the choice of antithrombin treatment during percutaneous coronary intervention. Increasing evidence suggests that treatment with the low molecular weight heparin enoxaparin during percutaneous coronary intervention (PCI) is safe and effective. Insufficient anticoagulation increases the risk of catheter thrombus formation during PCI. We report here a case with acute ST elevation myocardial infarction that periprocedural macroscopic thrombus formation on PCI equipment following antithrombin therapy with 0.75 mg/kg intravenously enoxaparin. All PCI equipments were removed and a bolus of intravenous UFH 100 U/kg was administered. New PCI equipments were inserted and the procedure was completed with stent implantation. Low molecular- weight heparin enoxaparin in the absence of a glycoprotein IIb/IIIa receptor blocker may be insufficient during percutaneous coronary intervention. Copyright © 2013 by Türkiye Klinik leri.
Açıklama
Anahtar Kelimeler
Angioplasty; Enoxaparin; Percutaneous coronary; Thrombosis; Transluminal
Kaynak
Turkiye Klinikleri Cardiovascular Sciences
WoS Q Değeri
Scopus Q Değeri
Q4
Cilt
25
Sayı
1
